Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 54 (3) , 125-131
- https://doi.org/10.1016/0304-3835(90)90033-t
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Pharmacological modification of multi‐drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t‐cellsInternational Journal of Cancer, 1990
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistanceInternational Journal of Cancer, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Human Medullary Thyroid Carcinoma in Culture Provides a Model Relating Growth Dynamics, Endocrine Cell Differentiation, and Tumor Progression*Journal of Clinical Endocrinology & Metabolism, 1984
- The Prognostic and Biological Significance of Cellular Heterogeneity in Medullary Thyroid Carcinoma: A Study of Calcitonin, L-Dopa Decarboxylase, and Histaminase*Journal of Clinical Endocrinology & Metabolism, 1982
- Management of hereditary medullary thyroid carcinomaClinics in Endocrinology and Metabolism, 1981